Apple launched watchOS 6.2.5 to the public last month, which enabled the EKG app for Apple Watch users in Saudi Arabia. And now the Apple Watch ECG may officially come to Brazil and Japan.
Last week, the Brazilian Food and Drug Administration (ANDA), which complies with the United States Food and Drug Administration (FDA), approved Apple’s ECG app in the country. The Brazilian government did one official statement Mention that both the electrocardiogram function and irregular heartbeat notifications can now be activated in Brazil.
And now, according to a new report, Apple is also registered as a certified manufacturer with the Japanese Agency for Pharmaceuticals and Medical Devices (PMDA) MacOtakara Report. The company was registered there on March 25, 2020, the same day that the Brazilian government announced approval of Apple’s EKG app.
Although it’s not clear in the Japanese documents what this registry is about, Apple has most likely also received approval to launch the EKG app in Japan.
Even with the approval of local authorities, the ECG app is not automatically made available to Apple Watch users in these countries. Apple usually needs to release a watchOS update to enable electrocardiogram and irregular heartbeat notifications in new countries. Therefore, it may take a while for these features to be available in Brazil and Japan.
The company is currently running tests with watchOS 6.2.8 Beta, but there is no evidence of EKG in more countries with this update – which of course can change until final release.
